Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 07/1/12 → 09/30/14 |
Funding
- Aastrom Biosciences Incorporated: $8,500.00
A multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy, safety, and tolerability of IXMYELOCEL-T in subjects with critical limb ischemia and no options for revascularization
- Dryjski, Maciej (PI)
- Cherr, Gregory (CoI)
- Harris, Linda (CoI)
Project: Research